BioSmart Co.,Ltd. (KOSDAQ:038460)
South Korea · Delayed Price · Currency is KRW 5,050.00
+120.00 (2.43%)
At close: Feb 13, 2026
BioSmart Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 7,215 | 127.17 | 17,907 | 721.31 | 1,392 | -8,737 |
Depreciation & Amortization | 8,114 | 8,204 | 8,490 | 9,572 | 5,632 | 5,314 |
Loss (Gain) From Sale of Assets | 32.88 | 315.55 | -16,442 | -143.33 | 341.1 | 6,353 |
Asset Writedown & Restructuring Costs | 1,538 | 1,830 | 1,355 | 54.55 | 3,036 | -18 |
Loss (Gain) From Sale of Investments | -1,002 | -972.67 | 1,576 | 102.27 | -283.56 | 255.17 |
Loss (Gain) on Equity Investments | -326.3 | -2,228 | 20.7 | -321.76 | 3,042 | 200.45 |
Provision & Write-off of Bad Debts | 105.89 | -362.6 | 1,270 | 603.54 | 149.35 | -108.6 |
Other Operating Activities | 11,974 | 9,655 | 2,391 | 4,274 | 799.81 | -5,993 |
Change in Accounts Receivable | -1,748 | -4,707 | -1,719 | -1,146 | -4,534 | -329.8 |
Change in Inventory | -5,978 | 2,574 | -1,871 | -6,246 | -594.6 | -2,781 |
Change in Accounts Payable | 7,544 | 2,983 | -4,637 | 1,972 | -2,564 | 4,385 |
Change in Other Net Operating Assets | -3,525 | -13,708 | -7,176 | -3,138 | -5,203 | -6,027 |
Operating Cash Flow | 23,946 | 3,708 | 1,166 | 6,289 | 1,203 | -7,487 |
Operating Cash Flow Growth | - | 218.15% | -81.47% | 422.93% | - | - |
Capital Expenditures | -5,187 | -6,922 | -3,113 | -4,359 | -5,332 | -8,362 |
Sale of Property, Plant & Equipment | 217.27 | 108.4 | 811.84 | 191.4 | 1,946 | 111.85 |
Cash Acquisitions | 15,004 | - | - | - | -26,748 | -811.75 |
Divestitures | - | - | 24,646 | 4,000 | - | - |
Sale (Purchase) of Intangibles | -459.86 | -1,739 | -1,804 | -1,508 | -531.3 | -890.05 |
Investment in Securities | 3,750 | 6,558 | -29,642 | 872.1 | -1,151 | 12,134 |
Other Investing Activities | 612.08 | 365.97 | 213.78 | -1,195 | -0.03 | 1,072 |
Investing Cash Flow | 4,953 | -8,825 | -8,834 | -2,028 | -31,797 | 2,798 |
Short-Term Debt Issued | - | 107,860 | 168,750 | 117,567 | 58,755 | 23,289 |
Long-Term Debt Issued | - | 10,000 | 11,000 | 11,900 | 21,517 | 6,643 |
Total Debt Issued | 68,814 | 117,860 | 179,750 | 129,467 | 80,272 | 29,931 |
Short-Term Debt Repaid | - | -129,299 | -161,955 | -97,983 | -54,179 | -23,400 |
Long-Term Debt Repaid | - | -7,717 | -11,734 | -24,931 | -7,348 | -4,449 |
Total Debt Repaid | -75,458 | -137,016 | -173,690 | -122,914 | -61,527 | -27,848 |
Net Debt Issued (Repaid) | -6,645 | -19,157 | 6,060 | 6,553 | 18,746 | 2,083 |
Issuance of Common Stock | 5,999 | 7,996 | - | - | 5,850 | 1,007 |
Repurchase of Common Stock | -9.3 | - | - | - | - | -2,992 |
Dividends Paid | - | - | - | -360 | - | -1,261 |
Other Financing Activities | -9,828 | 5,946 | -150.04 | -3,686 | -0 | -20 |
Financing Cash Flow | -10,294 | -5,025 | 8,910 | 2,507 | 24,596 | -1,183 |
Foreign Exchange Rate Adjustments | 54.76 | 12.35 | -2.57 | -39.34 | 30.69 | -1.61 |
Miscellaneous Cash Flow Adjustments | 90.02 | 90.02 | -0 | -701.69 | 1,125 | 0 |
Net Cash Flow | 18,749 | -10,040 | 1,239 | 6,027 | -4,843 | -5,874 |
Free Cash Flow | 18,759 | -3,213 | -1,947 | 1,930 | -4,129 | -15,849 |
Free Cash Flow Margin | 3.95% | -0.66% | -0.43% | 0.49% | -2.18% | -9.52% |
Free Cash Flow Per Share | 744.20 | -141.65 | -76.57 | 100.52 | -215.07 | -819.09 |
Cash Interest Paid | 2,228 | 3,327 | 4,088 | 2,567 | 1,242 | 1,232 |
Cash Income Tax Paid | 4,703 | 8,963 | 2,924 | 2,616 | 1,280 | 7,373 |
Levered Free Cash Flow | 10,914 | -7,160 | 201.02 | 9,029 | -14,664 | -13,265 |
Unlevered Free Cash Flow | 12,718 | -4,261 | 3,927 | 11,777 | -13,389 | -12,503 |
Change in Working Capital | -3,706 | -12,859 | -15,403 | -8,574 | -12,907 | -4,753 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.